Medtronic fined for monopoly pricing
Print Edition
CHINA’S top economic planner said yesterday that it has fined the Chinese unit of US medical device maker Medtronic 118.5 million yuan (US$17 million) for monopoly pricing.
It was the first price fixing case involving a medical device maker investigated by Chinese anti-monopoly regulators.
The National Development and Reform Commission said that since 2014, the company, which supplies cardiovascular, restorative and diabetes-related medical devices, has improperly suppressed competition through monopoly deals with distributors, and set minimum prices.
There is presently no full and open competition in the nation’s high-value and implantable medical device market. Medtronic’s minimum price deals for medical devices hurt patients, the NDRC said.
The fine represents 4 percent of 2015 sales volume of devices involved in the case. The company has already taken initiatives to correct the problem, the NDRC said.
- About Us
- |
- Terms of Use
- |
-
RSS - |
- Privacy Policy
- |
- Contact Us
- |
- Shanghai Call Center: 962288
- |
- Tip-off hotline: 52920043
- 娌狪CP璇侊細娌狪CP澶05050403鍙-1
- |
- 浜掕仈缃戞柊闂讳俊鎭湇鍔¤鍙瘉锛31120180004
- |
- 缃戠粶瑙嗗惉璁稿彲璇侊細0909346
- |
- 骞挎挱鐢佃鑺傜洰鍒朵綔璁稿彲璇侊細娌瓧绗354鍙
- |
- 澧炲肩數淇′笟鍔＄粡钀ヨ鍙瘉锛氭勃B2-20120012
Copyright 漏 1999- Shanghai Daily. All rights reserved.Preferably viewed with Internet Explorer 8 or newer browsers.
